SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Nanobac Pharmaceuticals Inc – ‘10KSB’ for 12/31/05 – EX-31.2

On:  Friday, 3/31/06, at 4:52pm ET   ·   For:  12/31/05   ·   Accession #:  1144204-6-13205   ·   File #:  33-80612

Previous ‘10KSB’:  ‘10KSB/A’ on 8/16/05 for 12/31/04   ·   Next:  ‘10KSB’ on 5/4/07 for 12/31/06   ·   Latest:  ‘10KSB’ on 4/15/08 for 12/31/07

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 3/31/06  Nanobac Pharmaceuticals Inc       10KSB      12/31/05    7:2.2M                                   Vintage/FA

Annual Report — Small Business   —   Form 10-KSB
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10KSB       Annual Report -- Small Business                     HTML    764K 
 2: EX-10.26    Material Contract                                   HTML      5K 
 3: EX-21.1     Subsidiaries of the Registrant                      HTML      7K 
 4: EX-31.1     Certification per Sarbanes-Oxley Act (Section 302)  HTML     15K 
 5: EX-31.2     Certification per Sarbanes-Oxley Act (Section 302)  HTML     15K 
 6: EX-32.1     Certification per Sarbanes-Oxley Act (Section 906)  HTML      8K 
 7: EX-32.2     Certification per Sarbanes-Oxley Act (Section 906)  HTML      8K 


EX-31.2   —   Certification per Sarbanes-Oxley Act (Section 302)


This exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]




Exhibit 31.2 - CERTIFICATION PURSUANT TO SARBANES-OXLEY SECTION 302

I, John D. Stanton, certify that:

1. I have reviewed this annual report on Form 10-KSB of Nanobac Pharmaceuticals, Incorporated;

2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this annual report;

3. Based on my knowledge, the financial statements, and other financial information included in this annual report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this annual report;

4. I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Registrant and have:

 
(d)
Designed such disclosure controls and procedures or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the Registrant including its consolidated subsidiaries, is made known to us by others within these entities, particularly during the period in which this report is being prepared;

 
(e)
Evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 
(f)
Disclosed in this report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting; and

5. I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of the Registrant’s board of directors (or persons performing the equivalent functions);

 
(c)
All significant deficiencies in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize and report financial data information; and

 
(d)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal controls over financial reporting.
 
     
 
 
 
 
 
 
Date: March 30, 2006 By:   /s/ John D. Stanton
 
John D. Stanton
 
Chief Financial Officer
 
 
 
 

 

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10KSB’ Filing    Date    Other Filings
Filed on:3/31/0610QSB
3/30/068-K
For Period End:12/31/05
 List all Filings 
Top
Filing Submission 0001144204-06-013205   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., Mar. 29, 4:11:36.1am ET